Melissa Stanton

Mayo Clinic in Arizona — United States

Medicine · Health Sciences

40h-index38.4kcitations111works4.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(36), Cancer Genomics and Diagnostics(36), Bladder and Urothelial Cancer Treatments(21), Renal and related cancers(20), Epigenetics and DNA Methylation(13)

Publications79 total

Morphologic and immunophenotypic characterization of conventional FLCN-mutated tumors (FMT) compared to a series of 8 non-conventional FMT
Human Pathology·2025· 7 cited
Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistry
Human Pathology·2025· 10 cited
Renal Neoplasia in Birt-Hogg-Dubé Syndrome: Integrated Histopathologic, Bulk, and Single-cell Transcriptomic Analysis
European Urology·2025· 13 cited
856 Assessing the Utility of GPNMB Immunohistochemistry as a Screen for Molecularly Defined Renal Neoplasia in 113 Consecutively Diagnosed Renal Cell Tumors
Laboratory Investigation·2025
795 Performance of an Artificial Intelligence Model for Recognition and Quantification of Testicular Germ Cell Tumors
Laboratory Investigation·2025
855 Molecular Profiling of Carbonic Anhydrase 9-Positive Renal Neoplasia with Clear Cell Features Including ELOC (TCEB1), MTOR, TSC1/TSC2-Mutated Renal Cell Carcinoma with Fibromyomatous Stroma
Laboratory Investigation·2025
857 Clinical-Grade Next Generation Sequencing of 200 Consecutive Patients with Renal Neoplasia
Laboratory Investigation·2025
Erratum for: Imaging of Upper Tract Urothelial Carcinoma
Radiographics·2024
Imaging of Upper Tract Urothelial Carcinoma
Radiographics·2024· 6 cited
The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate
Clinical Genitourinary Cancer·2024· 4 citedOpen Access
Single nucleotide polymorphism (SNP) chromosomal microarray as a diagnostic tool for mucinous tubular and spindle cell carcinoma: A validation study
Human Pathology·2024· 7 cited
Lurbinectedin in prostatic small cell and neuroendocrine carcinoma.
Journal of Clinical Oncology·2024· 2 cited
On Complete Clinical Response of Basal Cell Carcinoma of the Prostate After Definitive Concurrent Chemoradiation
Advances in Radiation Oncology·2023Open Access
Next generation sequencing-based identification of fusion-driven renal neoplasia: A single institution experience
Human Pathology·2023· 10 cited
Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcome
Clinical Epigenetics·2023· 9 citedOpen Access
Supplemental Table from PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation
2023Open Access
Data from PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation
2023Open Access
Supplemental Table from PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation
2023Open Access
Data from PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation
2023Open Access
Incidentally Discovered Right Atrial Mass: A Rare and Unexpected Etiology
Texas Heart Institute Journal·2023Open Access
page 1 of 4Next →

Frequent Co-authors

Thai H. Ho(21), Erik P. Castle(13), John C. Cheville(11), Richard W. Joseph(10), Sounak Gupta(9), Rafael E. Jiménez(8), Toni K. Choueiri(7), Alan H. Bryce(7), Jordan Reynolds(6), Rumeal D. Whaley(6), André P. Fay(5), David F. McDermott(5), Michael B. Atkins(5), Sabina Signoretti(5), Bradley C. Leibovich(5), Stephen A. Boorjian(5), Benjamin R. Kipp(5), Laurence Albigès(4), Alexander S. Parker(4), Kevin C. Halling(4)